Drug-Eluting Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
약물 용출 스텐트 시장 - 조사 범위
TMR의 보고서 "세계 약물 용출 스텐트 시장"은 2025-2035년 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하고 있습니다. 이 보고서는 2019년부터 2035년까지의 세계 약물 용출 스텐트 시장의 수익 및 예측을 제공하는데, 2025년은 기준 연도이며 2035년은 예측 연도로 간주됩니다. 또한, 2025-2035년까지의 세계 약물 용출 스텐트 시장의 연평균 성장률(CAGR %)을 제시합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 약물 용출 스텐트 시장을 이해하고자 했습니다.
| 시장 현황 |
| 2024년 시장 규모 |
77억 달러 |
| 2035년 시장 규모 |
142억 달러 |
| CAGR |
5.7% |
이 보고서는 세계 약물 용출 스텐트 시장의 경쟁 환경을 조사하고 있습니다. 세계 약물 용출 스텐트 시장에서 활동하는 주요 기업이 확인되었으며, 각 기업은 다양한 특성으로 프로파일링되었습니다. 회사 개요, 재무 상태, 최근 동향, SWOT는 세계 약물 용출 스텐트 시장 기업의 속성이며, 이 보고서에서 소개합니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약
제4장 시장 개요
- 소개
- 개요
- 시장 역학
- 세계의 약물 용출 스텐트 시장 분석과 예측, 2020-2035년
제5장 주요 인사이트
- 기술적 진보
- Porter's Five Forces 분석
- PESTEL 분석
- 공급망 분석
- 주요 업계 이벤트(합병, 인수, 제휴, 협업 등)
- 가격 분석(브랜드 가격, 지역/국가별 평균판매가격)
- 주요 국가·지역별 규제 시나리오
- 연구개발 동향
- 신규 시장 진입자를 위한 시장 개척 전략
제6장 세계의 시장 분석 및 예측 : 재료별
- 소개와 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 재료별, 2020-2035년
- 시장 매력 분석 : 재료별
제7장 세계의 시장 분석 및 예측 : 약제별
- 소개와 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 약제별, 2020-2035년
- 시롤리무스
- 파클리탁셀
- 조타롤리무스
- 에버롤리무스
- 기타
- 시장 매력 분석 : 약제별
제8장 세계의 시장 분석 및 예측 : 용도별
- 소개와 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 용도별, 2020-2035년
- 시장 매력 분석 : 용도별
제9장 세계의 시장 분석 및 예측 : 최종사용자별
- 소개와 정의
- 주요 조사 결과·발전
- 시장 금액 예측 : 최종사용자별, 2020-2035년
- 시장 매력 분석 : 최종사용자별
제10장 세계의 시장 분석 및 예측 : 지역별
- 주요 조사 결과
- 시장 금액 예측 : 지역별, 2020-2035년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- 시장 매력 분석 : 지역별
제11장 북미의 시장 분석과 예측
제12장 유럽의 시장 분석과 예측
제13장 아시아태평양의 시장 분석과 예측
제14장 라틴아메리카의 시장 분석과 예측
제15장 중동 및 아프리카의 시장 분석과 예측
제16장 경쟁 구도
- 시장 기업 - 경쟁 매트릭스(기업 계층별·규모별)
- 시장 점유율 분석 : 기업별(2024년)
- 기업 개요
- Abbott Laboratories
- AlviMedica
- B. Braun Melsungen AG
- Biosensors International Group, Ltd.
- Shandong JW Medical Systems LTD.
- Boston Scientific Corporation
- Cook Medical Inc.
- Elixir Medical Corp.
- Lepu Medical Technology(Beijing) Co., Ltd.
- Medtronic plc
- Eurocor GmbH
- OrbusNeich Medical Company Limited
- Shanghai MicroPort Medical Co., Ltd.
- Sino Medical Sciences Technology Inc.
KSM
Drug-Eluting Stents Market - Scope of Report
TMR's report on the global drug-eluting stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug-eluting stents market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug-eluting stents market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug-eluting stents market.
| Market Snapshot |
|---|
| Market Value in 2024 | US$ 7.7 Bn |
| Market Value in 2035 | US$ 14.2 Bn |
| CAGR | 5.7% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug-eluting stents market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug-eluting stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug-eluting stents market.
The report delves into the competitive landscape of the global drug-eluting stents market. Key players operating in the global drug-eluting stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug-eluting stents market profiled in this report.
Key Questions Answered in global drug-eluting stents Market Report:
- What is the sales/revenue generated by drug-eluting stents across all regions during the forecast period?
- What are the opportunities in the global drug-eluting stents market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2035?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Drug-Eluting Stents Market - Research Objectives and Research Approach
The comprehensive report on the global drug-eluting stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global drug-eluting stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug-eluting stents market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug-Eluting Stents Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Drug-Eluting Stents Market Analysis and Forecast, 2020-2035
- 4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
- 5.1. Technological Advancements
- 5.2. PORTER's Five Forces Analysis
- 5.3. PESTEL Analysis
- 5.4. Supply Chain Analysis
- 5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
- 5.6. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
- 5.7. Regulatory Scenario by Key Country/Region
- 5.8. Research and Development Trends
- 5.9. Go-to-Market Strategy for New Market Entrants
6. Global Drug-Eluting Stents Market Analysis and Forecast, by Material
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Material, 2020-2035
- 6.3.1. Metal
- 6.3.1.1. Stainless-Steel
- 6.3.1.2. Cobalt-Chromium
- 6.3.1.3. Nitinol
- 6.3.1.4. Others
- 6.3.2. Polymer
- 6.3.2.1. Non-biodegradable Polymers
- 6.3.2.2. Biodegradable Polymers
- 6.4. Market Attractiveness Analysis, by Material
7. Global Drug-Eluting Stents Market Analysis and Forecast, by Drug
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Drug, 2020-2035
- 7.3.1. Sirolimus
- 7.3.2. Paclitaxel
- 7.3.3. Zotarolimus
- 7.3.4. Everolimus
- 7.3.5. Others
- 7.4. Market Attractiveness Analysis, by Drug
8. Global Drug-Eluting Stents Market Analysis and Forecast, by Application
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by Application , 2020-2035
- 8.3.1. Coronary Artery Disease
- 8.3.2. Peripheral Artery Disease
- 8.3.3. Others
- 8.4. Market Attractiveness Analysis, by Application
9. Global Drug-Eluting Stents Market Analysis and Forecast, by End-user
- 9.1. Introduction & Definition
- 9.2. Key Findings/Developments
- 9.3. Market Value Forecast, by End-user, 2020-2035
- 9.3.1. Hospitals
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. Others
- 9.4. Market Attractiveness Analysis, by End-user
10. Global Drug-Eluting Stents Market Analysis and Forecast, by Region
- 10.1. Key Findings
- 10.2. Market Value Forecast, by Region, 2020-2035
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness By Region
11. North America Drug-Eluting Stents Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Material, 2020-2035
- 11.2.1. Metal
- 11.2.1.1. Stainless-Steel
- 11.2.1.2. Cobalt-Chromium
- 11.2.1.3. Nitinol
- 11.2.1.4. Others
- 11.2.2. Polymer
- 11.2.2.1. Non-biodegradable Polymers
- 11.2.2.2. Biodegradable Polymers
- 11.3. Market Value Forecast, by Drug, 2020-2035
- 11.3.1. Sirolimus
- 11.3.2. Paclitaxel
- 11.3.3. Zotarolimus
- 11.3.4. Everolimus
- 11.3.5. Others
- 11.4. Market Value Forecast, by Application , 2020-2035
- 11.4.1. Coronary Artery Disease
- 11.4.2. Peripheral Artery Disease
- 11.4.3. Others
- 11.5. Market Value Forecast, by End-user, 2020-2035
- 11.5.1. Hospitals
- 11.5.2. Ambulatory Surgical Centers
- 11.5.3. Others
- 11.6. Market Value Forecast, by Country, 2020-2035
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Material
- 11.7.2. By Drug
- 11.7.3. By Application
- 11.7.4. By End-user
- 11.7.5. By Country
12. Europe Drug-Eluting Stents Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Material, 2020-2035
- 12.2.1. Metal
- 12.2.1.1. Stainless-Steel
- 12.2.1.2. Cobalt-Chromium
- 12.2.1.3. Nitinol
- 12.2.1.4. Others
- 12.2.2. Polymer
- 12.2.2.1. Non-biodegradable Polymers
- 12.2.2.2. Biodegradable Polymers
- 12.3. Market Value Forecast, by Drug, 2020-2035
- 12.3.1. Sirolimus
- 12.3.2. Paclitaxel
- 12.3.3. Zotarolimus
- 12.3.4. Everolimus
- 12.3.5. Others
- 12.4. Market Value Forecast, by Application , 2020-2035
- 12.4.1. Coronary Artery Disease
- 12.4.2. Peripheral Artery Disease
- 12.4.3. Others
- 12.5. Market Value Forecast, by End-user, 2020-2035
- 12.5.1. Hospitals
- 12.5.2. Ambulatory Surgical Centers
- 12.5.3. Others
- 12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
- 12.6.1. Germany
- 12.6.2. UK
- 12.6.3. France
- 12.6.4. Italy
- 12.6.5. Spain
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Material
- 12.7.2. By Drug
- 12.7.3. By Application
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region
13. Asia Pacific Drug-Eluting Stents Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Material, 2020-2035
- 13.2.1. Metal
- 13.2.1.1. Stainless-Steel
- 13.2.1.2. Cobalt-Chromium
- 13.2.1.3. Nitinol
- 13.2.1.4. Others
- 13.2.2. Polymer
- 13.2.2.1. Non-biodegradable Polymers
- 13.2.2.2. Biodegradable Polymers
- 13.3. Market Value Forecast, by Drug, 2020-2035
- 13.3.1. Sirolimus
- 13.3.2. Paclitaxel
- 13.3.3. Zotarolimus
- 13.3.4. Everolimus
- 13.3.5. Others
- 13.4. Market Value Forecast, by Application , 2020-2035
- 13.4.1. Coronary Artery Disease
- 13.4.2. Peripheral Artery Disease
- 13.4.3. Others
- 13.5. Market Value Forecast, by End-user, 2020-2035
- 13.5.1. Hospitals
- 13.5.2. Ambulatory Surgical Centers
- 13.5.3. Others
- 13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Material
- 13.7.2. By Drug
- 13.7.3. By Application
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region
14. Latin America Drug-Eluting Stents Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Material, 2020-2035
- 14.2.1. Metal
- 14.2.1.1. Stainless-Steel
- 14.2.1.2. Cobalt-Chromium
- 14.2.1.3. Nitinol
- 14.2.1.4. Others
- 14.2.2. Polymer
- 14.2.2.1. Non-biodegradable Polymers
- 14.2.2.2. Biodegradable Polymers
- 14.3. Market Value Forecast, by Drug, 2020-2035
- 14.3.1. Sirolimus
- 14.3.2. Paclitaxel
- 14.3.3. Zotarolimus
- 14.3.4. Everolimus
- 14.3.5. Others
- 14.4. Market Value Forecast, by Application , 2020-2035
- 14.4.1. Coronary Artery Disease
- 14.4.2. Peripheral Artery Disease
- 14.4.3. Others
- 14.5. Market Value Forecast, by End-user, 2020-2035
- 14.5.1. Hospitals
- 14.5.2. Ambulatory Surgical Centers
- 14.5.3. Others
- 14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Material
- 14.7.2. By Drug
- 14.7.3. By Application
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region
15. Middle East & Africa Drug-Eluting Stents Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Material, 2020-2035
- 15.2.1. Metal
- 15.2.1.1. Stainless-Steel
- 15.2.1.2. Cobalt-Chromium
- 15.2.1.3. Nitinol
- 15.2.1.4. Others
- 15.2.2. Polymer
- 15.2.2.1. Non-biodegradable Polymers
- 15.2.2.2. Biodegradable Polymers
- 15.3. Market Value Forecast, by Drug, 2020-2035
- 15.3.1. Sirolimus
- 15.3.2. Paclitaxel
- 15.3.3. Zotarolimus
- 15.3.4. Everolimus
- 15.3.5. Others
- 15.4. Market Value Forecast, by Application , 2020-2035
- 15.4.1. Coronary Artery Disease
- 15.4.2. Peripheral Artery Disease
- 15.4.3. Others
- 15.5. Market Value Forecast, by End-user, 2020-2035
- 15.5.1. Hospitals
- 15.5.2. Ambulatory Surgical Centers
- 15.5.3. Others
- 15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
- 15.7. Market Attractiveness Analysis
- 15.7.1. By Material
- 15.7.2. By Drug
- 15.7.3. By Application
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region
16. Competition Landscape
- 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
- 16.2. Market Share Analysis, by Company (2024)
- 16.3. Company Profiles
- 16.3.1. Abbott Laboratories
- 16.3.1.1. Company Overview
- 16.3.1.2. Financial Overview
- 16.3.1.3. Product Portfolio
- 16.3.1.4. Business Strategies
- 16.3.1.5. Recent Developments
- 16.3.2. AlviMedica
- 16.3.2.1. Company Overview
- 16.3.2.2. Financial Overview
- 16.3.2.3. Product Portfolio
- 16.3.2.4. Business Strategies
- 16.3.2.5. Recent Developments
- 16.3.3. B. Braun Melsungen AG
- 16.3.3.1. Company Overview
- 16.3.3.2. Financial Overview
- 16.3.3.3. Product Portfolio
- 16.3.3.4. Business Strategies
- 16.3.3.5. Recent Developments
- 16.3.4. Biosensors International Group, Ltd.
- 16.3.4.1. Company Overview
- 16.3.4.2. Financial Overview
- 16.3.4.3. Product Portfolio
- 16.3.4.4. Business Strategies
- 16.3.4.5. Recent Developments
- 16.3.5. Shandong JW Medical Systems LTD.
- 16.3.5.1. Company Overview
- 16.3.5.2. Financial Overview
- 16.3.5.3. Product Portfolio
- 16.3.5.4. Business Strategies
- 16.3.5.5. Recent Developments
- 16.3.6. Boston Scientific Corporation
- 16.3.6.1. Company Overview
- 16.3.6.2. Financial Overview
- 16.3.6.3. Product Portfolio
- 16.3.6.4. Business Strategies
- 16.3.6.5. Recent Developments
- 16.3.7. Cook Medical Inc.
- 16.3.7.1. Company Overview
- 16.3.7.2. Financial Overview
- 16.3.7.3. Product Portfolio
- 16.3.7.4. Business Strategies
- 16.3.7.5. Recent Developments
- 16.3.8. Elixir Medical Corp.
- 16.3.8.1. Company Overview
- 16.3.8.2. Financial Overview
- 16.3.8.3. Product Portfolio
- 16.3.8.4. Business Strategies
- 16.3.8.5. Recent Developments
- 16.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
- 16.3.9.1. Company Overview
- 16.3.9.2. Financial Overview
- 16.3.9.3. Product Portfolio
- 16.3.9.4. Business Strategies
- 16.3.9.5. Recent Developments
- 16.3.10. Medtronic plc
- 16.3.10.1. Company Overview
- 16.3.10.2. Financial Overview
- 16.3.10.3. Product Portfolio
- 16.3.10.4. Business Strategies
- 16.3.10.5. Recent Developments
- 16.3.11. Eurocor GmbH
- 16.3.11.1. Company Overview
- 16.3.11.2. Financial Overview
- 16.3.11.3. Product Portfolio
- 16.3.11.4. Business Strategies
- 16.3.11.5. Recent Developments
- 16.3.12. OrbusNeich Medical Company Limited
- 16.3.12.1. Company Overview
- 16.3.12.2. Financial Overview
- 16.3.12.3. Product Portfolio
- 16.3.12.4. Business Strategies
- 16.3.12.5. Recent Developments
- 16.3.13. Shanghai MicroPort Medical Co., Ltd.
- 16.3.13.1. Company Overview
- 16.3.13.2. Financial Overview
- 16.3.13.3. Product Portfolio
- 16.3.13.4. Business Strategies
- 16.3.13.5. Recent Developments
- 16.3.14. Sino Medical Sciences Technology Inc.
- 16.3.14.1. Company Overview
- 16.3.14.2. Financial Overview
- 16.3.14.3. Product Portfolio
- 16.3.14.4. Business Strategies
- 16.3.14.5. Recent Developments
